Result:Weak· Market: Crashed#Margin expansion
| Metric | Value (₹ Cr) | Q1 FY26 |
|---|---|---|
| Revenue | 3.15 | 41.8% |
| Total Income | 3.18 | 42.1% |
| Expenditure | 2.88 | 43.5% |
| PBT | 0.30 | 22.5% |
| Net Profit | 0.23 | 23.9% |
| OPM | 10.12% | 3.69pp |
| NPM | 7.24% | 1.74pp |
| EPS | 0.77 | 23.8% |
Pharma small-cap with revenue down a sharp 41.8% YoY and adjusted PAT down 23.9%, a clear decline on the core growth metric despite better OPM%.
Informational and educational content only. Not investment advice.